• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalene sulfonic acids and derivatives 2-naphthalene sulfonic acids and derivatives

Comprehensive Overview of N-3-(6-ethoxypyridazin-3-yl)phenylnaphthalene-2-sulfonamide (CAS No. 941959-29-1)

N-3-(6-ethoxypyridazin-3-yl)phenylnaphthalene-2-sulfonamide (CAS No. 941959-29-1) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This sulfonamide derivative features a unique molecular structure combining a naphthalene core with a pyridazine moiety, making it a promising candidate for various applications. Researchers are particularly interested in its potential as a kinase inhibitor, a hot topic in drug discovery for treating cancers and inflammatory diseases.

The compound's molecular formula and structural complexity contribute to its bioactive properties. With the growing demand for targeted therapies in precision medicine, N-3-(6-ethoxypyridazin-3-yl)phenylnaphthalene-2-sulfonamide is being studied for its selective interactions with specific enzymes. Its ethoxypyridazine group enhances solubility, while the naphthalenesulfonamide portion provides structural stability—key factors driving its research applications.

Recent studies highlight the compound's potential in addressing drug-resistant infections, a critical global health challenge. The sulfonamide group in its structure shows affinity for bacterial enzymes, aligning with current searches for novel antimicrobial agents. This positions CAS No. 941959-29-1 as relevant to trending searches about antibiotic alternatives and next-generation therapeutics.

From a synthetic chemistry perspective, the compound's multi-ring system presents interesting challenges for structure-activity relationship (SAR) studies. Researchers are optimizing its synthesis to improve yield and purity—common queries in organic synthesis forums. The ethoxy group modification allows for fine-tuning of pharmacokinetic properties, a frequent focus in medicinal chemistry discussions.

The commercial availability of N-3-(6-ethoxypyridazin-3-yl)phenylnaphthalene-2-sulfonamide has increased due to demand from drug discovery programs. Suppliers often list it alongside small molecule inhibitors and research chemicals, reflecting current market trends. Analytical data shows growing interest from academic institutions and biotech startups working on personalized medicine approaches.

Environmental and safety studies indicate that this compound requires standard laboratory handling procedures. While not classified as hazardous, proper chemical storage conditions are recommended—a common concern among laboratory professionals searching for compound handling guidelines. Its stability profile makes it suitable for various biochemical assays and high-throughput screening applications.

Future research directions for CAS No. 941959-29-1 may explore its potential in neurodegenerative disease research, given the increasing search volume for Alzheimer's therapeutics. The compound's ability to cross the blood-brain barrier is under investigation, connecting it to another trending topic in CNS drug development.

For researchers seeking custom synthesis or bulk quantities of N-3-(6-ethoxypyridazin-3-yl)phenylnaphthalene-2-sulfonamide, several specialized manufacturers offer GMP-grade material. The compound's patent status and intellectual property considerations are frequently searched aspects, reflecting the business dimension of pharmaceutical research.

In analytical applications, this compound serves as a valuable reference standard for method development. Laboratories performing HPLC analysis or mass spectrometry often inquire about its spectral data, making technical specifications important for SEO optimization. The presence of both aromatic and heterocyclic components makes it particularly useful for chromatography studies.

The scientific community continues to investigate the full potential of N-3-(6-ethoxypyridazin-3-yl)phenylnaphthalene-2-sulfonamide, with new publications emerging regularly. Its combination of pharmacological activity and structural novelty ensures ongoing relevance in chemical biology and drug design—fields experiencing exponential growth according to recent search trends.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)